Compare CMPX & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPX | HAFC |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.5M | 821.2M |
| IPO Year | 2020 | 2000 |
| Metric | CMPX | HAFC |
|---|---|---|
| Price | $1.98 | $29.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | $14.57 | ★ $32.17 |
| AVG Volume (30 Days) | ★ 11.9M | 228.0K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | N/A | ★ 22.44 |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $270,165,000.00 |
| Revenue This Year | N/A | $18.65 |
| Revenue Next Year | $934.41 | $7.28 |
| P/E Ratio | ★ N/A | $38.80 |
| Revenue Growth | N/A | ★ 15.28 |
| 52 Week Low | $1.61 | $21.84 |
| 52 Week High | $6.88 | $31.33 |
| Indicator | CMPX | HAFC |
|---|---|---|
| Relative Strength Index (RSI) | 27.93 | 51.92 |
| Support Level | $1.61 | $29.20 |
| Resistance Level | $3.68 | $29.46 |
| Average True Range (ATR) | 0.23 | 0.68 |
| MACD | 0.02 | -0.21 |
| Stochastic Oscillator | 42.31 | 15.29 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.